Plasmon-Enhanced Digital Fluoroimmunoassay for Subfemtomolar Detection of Protein Biomarkers
Nano Letters · 10.01.2024 · 24 (1) · 229-237
DOI: 10.1021/acs.nanolett.3c03789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 26.12.2023. Verfasst von Anushree Seth und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St. L…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Rapid and accurate quantification of low-abundance protein biomarkers in biofluids can transform the diagnosis of a range of pathologies, including infectious diseases. Here, we harness ultrabright plasmonic fluors as "digital nanolabels" and demonstrate the detection and quantification of subfemtomolar concentrations of human IL-6 and SARS-CoV-2 alpha and variant proteins in clinical nasopharyngeal swab and saliva samples from COVID-19 patients. The resulting digital plasmonic fluor-linked immunosorbent assay (digital p-FLISA) enables detection of SARS-CoV-2 nucleocapsid protein, both in solution and in live virions. Digital p-FLISA outperforms the "gold standard" enzyme-linked immunosorbent assay (ELISA), having a nearly 7000-fold lower limit-of-detection, and outperforms a commercial antigen test, having over 5000-fold improvement in analytical sensitivity. Detection and quantification of very low concentrations of target proteins holds potential for early detection of pathological conditions, treatment monitoring, and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States.
- Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63130, United States.
- Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri 63110, United States.
- Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
- Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri 63110, United States.
ORCID-Profile: Anushree Seth, Prashant Gupta, Guy M Genin, Srikanth Singamaneni
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Cancer Institute
- Division of Civil, Mechanical and Manufacturing Innovation
- Division of Chemical, Bioengineering, Environmental, and Transport Systems
- National Institutes of Health
Zitieren
APA
Seth, A., Liu, Y., Gupta, R., Wang, Z., Mittal, E., Kolla, S., Rathi, P., Gupta, P., Parikh, B. A., Genin, G. M., Gandra, S., Storch, G. A., Philips, J. A., George, I. A., & Singamaneni, S. (2024). Plasmon-Enhanced Digital Fluoroimmunoassay for Subfemtomolar Detection of Protein Biomarkers. Nano Letters, 24(1), 229-237. https://doi.org/10.1021/acs.nanolett.3c03789
Vancouver
Seth A, Liu Y, Gupta R, Wang Z, Mittal E, Kolla S, et al. Plasmon-Enhanced Digital Fluoroimmunoassay for Subfemtomolar Detection of Protein Biomarkers. Nano Letters. 2024;24(1):229-237. doi:10.1021/acs.nanolett.3c03789
BibTeX
@article{Seth2024,
author = {Seth, Anushree and Liu, Yuxiong and Gupta, Rohit and Wang, Zheyu and Mittal, Ekansh and Kolla, Samhitha and Rathi, Priya and Gupta, Prashant and Parikh, Bijal A and Genin, Guy M and Gandra, Sumanth and Storch, Gregory A and Philips, Jennifer A and George, Ige A and Singamaneni, Srikanth},
title = {Plasmon-Enhanced Digital Fluoroimmunoassay for Subfemtomolar Detection of Protein Biomarkers},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {1},
pages = {229--237},
doi = {10.1021/acs.nanolett.3c03789}
}
EUVIMED